256 related articles for article (PubMed ID: 14977820)
1. Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia.
Al-Aynati MM; Radulovich N; Riddell RH; Tsao MS
Clin Cancer Res; 2004 Feb; 10(4):1235-40. PubMed ID: 14977820
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.
Stark AP; Chang HH; Jung X; Moro A; Hertzer K; Xu M; Schmidt A; Hines OJ; Eibl G
Surgery; 2015 Dec; 158(6):1564-72. PubMed ID: 26297056
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
Joo YE; Rew JS; Park CS; Kim SJ
Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells.
Prasad NB; Biankin AV; Fukushima N; Maitra A; Dhara S; Elkahloun AG; Hruban RH; Goggins M; Leach SD
Cancer Res; 2005 Mar; 65(5):1619-26. PubMed ID: 15753353
[TBL] [Abstract][Full Text] [Related]
5. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.
Chetty R; Serra S; Salahshor S; Alsaad K; Shih W; Blaszyk H; Woodgett JR; Tsao MS
Hum Pathol; 2006 Feb; 37(2):212-7. PubMed ID: 16426922
[TBL] [Abstract][Full Text] [Related]
6. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
7. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia.
Lee KM; Cao D; Itami A; Pour PM; Hruban RH; Maitra A; Ouellette MM
Histopathology; 2007 Oct; 51(4):539-46. PubMed ID: 17714470
[TBL] [Abstract][Full Text] [Related]
8. Expression of the E-cadherin-catenin complex in patients with pancreatic ductal adenocarcinoma.
Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
Folia Histochem Cytobiol; 2010 Jan; 48(1):128-33. PubMed ID: 20529828
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Li YJ; Wei ZM; Meng YX; Ji XR
World J Gastroenterol; 2005 Apr; 11(14):2117-23. PubMed ID: 15810077
[TBL] [Abstract][Full Text] [Related]
11. Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma.
Sarkar S; Mandal C; Sangwan R; Mandal C
Endocr Relat Cancer; 2014 Feb; 21(1):113-25. PubMed ID: 24402132
[TBL] [Abstract][Full Text] [Related]
12. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
14. alpha-, beta- and chi-catenin expression in human pancreatic cancer.
Julkunen K; Mäkinen K; Kärjä V; Kosma VM; Eskelinen M
Anticancer Res; 2003; 23(6D):5043-7. PubMed ID: 14981965
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium.
Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H
Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma.
Lowy AM; Fenoglio-Preiser C; Kim OJ; Kordich J; Gomez A; Knight J; James L; Groden J
Ann Surg Oncol; 2003 Apr; 10(3):284-90. PubMed ID: 12679314
[TBL] [Abstract][Full Text] [Related]
17. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
18. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model.
Sormunen RT; Leong AS; Vääräniemi JP; Fernando SS; Eskelinen SM
J Pathol; 1999 Mar; 187(4):416-23. PubMed ID: 10398100
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.
Fernebro E; Bendahl PO; Dictor M; Persson A; Fernö M; Nilbert M
Int J Cancer; 2004 Oct; 111(6):921-8. PubMed ID: 15300804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
